Impact of Prenatal Exposure to Serotonin Reuptake Inhibitors or Maternal Major Depressive Disorder on Infant Developmental Outcomes

Overview

Journal J Clin Psychiatry

Specialty Psychiatry

Date 2014 Nov 6

PMID 25373117

Citations 21

Authors

Aimee K Santucci

Lynn T Singer

Stephen R Wisniewski

James F Luther

Heather F Eng

John L Dills

Dorothy K Y Sit

Barbara H Hanusa

Katherine L Wisner

Affiliations

Soon will be listed here.

Abstract

Objective: To examine the impact of prenatal exposure to both serotonin reuptake inhibitors (SRIs; during any trimester) and maternal major depressive disorder (MDD; by DSM-IV criteria) on infant functioning. We hypothesized that infants with prenatal exposure to SRIs or MDD would have lower psychomotor, mental, and behavioral scores compared with nonexposed infants.

Method: This longitudinal study included 166 mother-infant dyads: 68 with prenatal MDD/SRI (n = 41) or MDD/no SRI exposure (n = 27) and 98 nonexposed controls. Maternal depression and SRI exposure assessments were completed at or as near to 20, 30, and 36 prenatal weeks and 12, 26, 52, and 78 weeks postpartum as feasible. Infants were evaluated with the Bayley Scales of Infant Development, Second Edition, including the psychomotor (Psychomotor Development Index; PDI), cognitive (Mental Development Index; MDI), and behavioral (Behavioral Rating Scale; BRS) components. Study assessments occurred between 2003 and 2009.

Results: Neither prenatal exposure to MDD/SRI nor MDD/no SRI significantly impacted overall PDI, MDI, or BRS scores. However, we observed a significant SRI exposure by time interaction for the PDI (P = .038). MDD/SRI exposure was associated with lower PDI scores at 26 (mean = 97.0) and 52 weeks (mean = 92.9) compared with nonexposed infants (mean = 101.4 and 100.5). This difference was no longer significant at the 78-week assessment.

Conclusions: Consistent with previous studies, we found no impact of prenatal MDD/SRI exposure on MDI scores. Less favorable PDI scores were observed in the first year; notably, these scores remained well within the normative range. The effects of prenatal MDD/SRI exposure on motor functioning may be transitory. A longitudinal pattern of poor developmental outcomes has not been established.

Trial Registration: ClinicalTrials.gov identifier: NCT00279370.

Citing Articles

Antidepressants use during pregnancy and child psychomotor, cognitive and language development at 2 years of age-Results from the 3D Cohort Study.

Tanguay N, Abdelouahab N, Simard M, Seguin J, Marc I, Herba C Front Pharmacol. 2023; 14:1252251.

PMID: 38035027 PMC: 10687276. DOI: 10.3389/fphar.2023.1252251.

Psychiatric illness and pregnancy: A literature review.

Abdelhafez M, Ahmed K, Ahmed N, Ismail M, Mohd Daud M, Ping N Heliyon. 2023; 9(11):e20958.

PMID: 37954333 PMC: 10632674. DOI: 10.1016/j.heliyon.2023.e20958.

Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child.

Lebin L, Novick A Curr Psychiatry Rep. 2022; 24(11):687-695.

PMID: 36181572 PMC: 10590209. DOI: 10.1007/s11920-022-01372-x.

Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study.

Benevent J, Hurault-Delarue C, Araujo M, Revet A, Sommet A, Lacroix I Front Psychiatry. 2022; 13:795890.

PMID: 35392389 PMC: 8980541. DOI: 10.3389/fpsyt.2022.795890.

Fifty Years of Research on Prenatal Substances: Lessons Learned for the Opioid Epidemic.

Singer L, Chambers C, Coles C, Kable J Advers Resil Sci. 2021; 1(4):223-234.

PMID: 34316723 PMC: 8312986. DOI: 10.1007/s42844-020-00021-7.

References

Wisner K, Sit D, Hanusa B, Moses-Kolko E, Bogen D, Hunker D . Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009; 166(5):557-66. PMC: 4426499. DOI: 10.1176/appi.ajp.2008.08081170. View

Forcada-Guex M, Pierrehumbert B, Borghini A, Moessinger A, Muller-Nix C . Early dyadic patterns of mother-infant interactions and outcomes of prematurity at 18 months. Pediatrics. 2006; 118(1):e107-14. DOI: 10.1542/peds.2005-1145. View

Zuckerman B, Bauchner H, Parker S, Cabral H . Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr. 1990; 11(4):190-4. View

Wadhwa P . Psychoneuroendocrine processes in human pregnancy influence fetal development and health. Psychoneuroendocrinology. 2005; 30(8):724-43. DOI: 10.1016/j.psyneuen.2005.02.004. View

OConnor T, Heron J, Golding J, Beveridge M, Glover V . Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry. 2002; 180:502-8. DOI: 10.1192/bjp.180.6.502. View

Einarson A, Schachtschneider A, Halil R, Bollano E, Koren G . SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth. 2005; 5:11. PMC: 1156906. DOI: 10.1186/1471-2393-5-11. View

Nulman I, Rovet J, Stewart D, Wolpin J, Gardner H, Theis J . Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997; 336(4):258-62. DOI: 10.1056/NEJM199701233360404. View

Sodhi M, Sanders-Bush E . Serotonin and brain development. Int Rev Neurobiol. 2004; 59:111-74. DOI: 10.1016/S0074-7742(04)59006-2. View

Pedersen L, Henriksen T, Olsen J . Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics. 2010; 125(3):e600-8. DOI: 10.1542/peds.2008-3655. View

10.

Oberlander T, Papsdorf M, Brain U, Misri S, Ross C, Grunau R . Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med. 2010; 164(5):444-51. DOI: 10.1001/archpediatrics.2010.51. View

11.

Casper R, Gilles A, Fleisher B, Baran J, Enns G, Lazzeroni L . Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl). 2011; 217(2):211-9. DOI: 10.1007/s00213-011-2270-z. View

12.

Nichols R . Serotonin, presynaptic 5-HT₃ receptors and synaptic plasticity in the developing cerebellum. J Physiol. 2011; 589(Pt 21):5019-20. PMC: 3225662. DOI: 10.1113/jphysiol.2011.219782. View

13.

Keller M, Lavori P, Friedman B, Nielsen E, Endicott J, Andreasen N . The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987; 44(6):540-8. DOI: 10.1001/archpsyc.1987.01800180050009. View

14.

Yonkers K, Gotman N, Smith M, Forray A, Belanger K, Brunetto W . Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?. Epidemiology. 2011; 22(6):848-54. PMC: 3188383. DOI: 10.1097/EDE.0b013e3182306847. View

15.

Oberlander T, Gingrich J, Ansorge M . Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009; 86(6):672-7. PMC: 3963518. DOI: 10.1038/clpt.2009.201. View

16.

Deave T, Heron J, Evans J, Emond A . The impact of maternal depression in pregnancy on early child development. BJOG. 2008; 115(8):1043-51. DOI: 10.1111/j.1471-0528.2008.01752.x. View

17.

Pedersen L, Henriksen T, Bech B, Licht R, Kjaer D, Olsen J . Prenatal antidepressant exposure and behavioral problems in early childhood--a cohort study. Acta Psychiatr Scand. 2012; 127(2):126-35. DOI: 10.1111/acps.12032. View

18.

Palmsten K, Hernandez-Diaz S . Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?. Epidemiology. 2012; 23(5):686-8. PMC: 4133936. DOI: 10.1097/EDE.0b013e318258fbb2. View

19.

Johnson K, LaPrairie J, Brennan P, Stowe Z, Newport D . Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012; 69(8):787-94. PMC: 4714592. DOI: 10.1001/archgenpsychiatry.2012.160. View

20.

Yonkers K, Wisner K, Stewart D, Oberlander T, Dell D, Stotland N . The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009; 31(5):403-13. PMC: 3094693. DOI: 10.1016/j.genhosppsych.2009.04.003. View